Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

378 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comprehensive genetic profiling reveals frequent alterations of driver genes on the X chromosome in extranodal NK/T-cell lymphoma.
Ito Y, Marouf A, Kogure Y, Koya J, Liévin R, Bruneau J, Tabata M, Saito Y, Shingaki S, Yuasa M, Yamaguchi K, Murakami K, Weil R, Vavasseur M, Andrieu GP, Latiri M, Veleanu L, Dussiot M, André I, Joshi A, Lagresle-Peyrou C, Magerus A, Chaubard S, Lavergne D, Bachy E, Brunet E, Fataccioli V, Brouzes C, Laurent C, De Leval L, Traverse-Glehen A, Bossard C, Parrens MC, Meignin V, Philippe L, Rossignol J, Suarez F, Michot JM, Tournilhac O, Damaj G, Lemonnier F, Bôle-Feysot C, Nitschké P, Tesson B, Laurent C, Molina T, Asnafi V, Watatani Y, Chiba K, Okada A, Shiraishi Y, Tsukita S, Izutsu K, Miyoshi H, Ohshima K, Sakata S, Dobashi A, Takeuchi K, Sanada M, Gaulard P, Jaccard A, Ogawa S, Hermine O, Kataoka K, Couronné L. Ito Y, et al. Among authors: lemonnier f. Cancer Res. 2024 Apr 24. doi: 10.1158/0008-5472.CAN-24-0132. Online ahead of print. Cancer Res. 2024. PMID: 38657099
Separating the Wheat from the Chaff among HLA-DQ Eplets.
Devriese M, Lemonnier FA, Lion J, Sayegh C, Fleury E, Shofstall C, Giraldo L, Fiachetti Q, Usureau C, Miyadera H, Toutirais O, Mooney N, Lowe D, Taupin JL. Devriese M, et al. Among authors: lemonnier fa. J Immunol. 2024 Apr 22:ji2400030. doi: 10.4049/jimmunol.2400030. Online ahead of print. J Immunol. 2024. PMID: 38647382
[Pilot study of a health promotion intervention in sports clubs].
Tezier B, Van Hoye A, Vuillemin A, Lemonnier F, Rostan F, Guillemin F. Tezier B, et al. Among authors: lemonnier f. Sante Publique. 2024 Apr 5;36(1):7-22. doi: 10.3917/spub.241.0007. Sante Publique. 2024. PMID: 38580468 French.
Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment.
Krug A, Tosolini M, Madji Hounoum B, Fournié JJ, Geiger R, Pecoraro M, Emond P, Gaulard P, Lemonnier F, Ricci JE, Verhoeyen E. Krug A, et al. Among authors: lemonnier f. J Exp Clin Cancer Res. 2024 Feb 6;43(1):43. doi: 10.1186/s13046-024-02952-w. J Exp Clin Cancer Res. 2024. PMID: 38321568 Free PMC article.
Clinical and histological study of follicular helper T-cell lymphomas with indolent evolution.
Messéant O, Drieux F, Sako N, Fataccioli V, Camus V, Robe C, Houot R, Tas P, Llamas-Gutierrez F, Lamaison C, Abraham J, Delage-Corre M, Benguerfi S, Bossard JB, Gaulard P, Lemonnier F. Messéant O, et al. Among authors: lemonnier f. Eur J Cancer. 2024 Jan;197:113479. doi: 10.1016/j.ejca.2023.113479. Epub 2023 Dec 12. Eur J Cancer. 2024. PMID: 38128263
Angioimmunoblastic T-cell lymphoma and Kaposi sarcoma: A fortuitous collision?
Poullot E, Milowich D, Lemonnier F, Bisig B, Robe C, Pelletier L, Letourneau A, Dupuy A, Sako N, Ketterer N, Carde P, Dartigues P, Delfau-Larue MH, de Leval L, Gaulard P. Poullot E, et al. Among authors: lemonnier f. Histopathology. 2024 Feb;84(3):556-564. doi: 10.1111/his.15083. Epub 2023 Nov 21. Histopathology. 2024. PMID: 37988271
A health promoting sports club framework: strategies from the field.
Johnson S, Van Hoye A, Geidne S, Donaldson A, Rostan F, Lemonnier F, Tezier B, Vuillemin A. Johnson S, et al. Among authors: lemonnier f. Glob Health Promot. 2024 Mar;31(1):85-90. doi: 10.1177/17579759231195562. Epub 2023 Oct 14. Glob Health Promot. 2024. PMID: 37837371
Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
Houot R, Bachy E, Cartron G, Gros FX, Morschhauser F, Oberic L, Gastinne T, Feugier P, Duléry R, Thieblemont C, Joris M, Jardin F, Choquet S, Casasnovas O, Brisou G, Cheminant M, Bay JO, Gutierrez FL, Menard C, Tarte K, Delfau MH, Portugues C, Itti E, Palard-Novello X, Blanc-Durand P, Al Tabaa Y, Bailly C, Laurent C, Lemonnier F. Houot R, et al. Among authors: lemonnier f. Nat Med. 2023 Oct;29(10):2665. doi: 10.1038/s41591-023-02624-w. Nat Med. 2023. PMID: 37814064 Free PMC article. No abstract available.
Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
Houot R, Bachy E, Cartron G, Gros FX, Morschhauser F, Oberic L, Gastinne T, Feugier P, Duléry R, Thieblemont C, Joris M, Jardin F, Choquet S, Casasnovas O, Brisou G, Cheminant M, Bay JO, Gutierrez FL, Menard C, Tarte K, Delfau MH, Portugues C, Itti E, Palard-Novello X, Blanc-Durand P, Al Tabaa Y, Bailly C, Laurent C, Lemonnier F. Houot R, et al. Among authors: lemonnier f. Nat Med. 2023 Oct;29(10):2593-2601. doi: 10.1038/s41591-023-02572-5. Epub 2023 Sep 14. Nat Med. 2023. PMID: 37710005 Free PMC article. Clinical Trial.
378 results